VCU Pain And neuropathy Research Program Neuropharmacology of drug addiction and pain- nicotinic Lab

Virginia, USA
Joined June 2015
Our latest in the Journal of Pain @TheJournal_Pain : A critical role for α7 nicotinic acetylcholine receptor signaling in myeloid lineage cells in chronic neuropathic and inflammatory pain responses sciencedirect.com/science/ar…
2
6
332
Our latest on adolescent nicotine “Adolescent nicotine exposure affects later-life nicotine reward and withdrawal in mice” with the talented graduate student @BuzziBelle sciencedirect.com/science/ar…
1
3
295
Imad Damaj retweeted
Check out this #PapersoftheWeek pick from @Edaksl14 and @ELSpharma’s Pharmacological Research about psychedelics psilocybin and DOI dose-dependently reversing pain-like behaviors through serotonergic receptor activity in mouse models of chronic pain bit.ly/4l2kRAj #PRF
1
2
4
2,094
Check out our newest paper with the talented former Ph.D. Student @BD_Mckiver ! Astrocyte elevated gene-1 (AEG-1) in myeloid cells is a key driver for the development of chemotherapy-induced peripheral neuropathy. sciencedirect.com/science/ar…
6
1
13
1,202
Just out: psychedelics in action! Our paper in collaboration with Javier Gonzalez-Maeso group and awesome members of the lab @BuzziBelle and Eda Köşeli demonstrating the long lasting effects of a single dose of psilocybin in mouse models of chronic pain. sciencedirect.com/science/ar…
8
21
1,727
Join us on this interesting conference!
🚨 Exciting news! 🚨 We’re thrilled to announce the schedule & speaker lineup for our virtual conference on March 7, 2025! 🎉 Stay tuned for details, and get ready for an incredible event! 🔗 isrpsych.org/conferences #ISRP2025
2
229
Imad Damaj retweeted
A new paper characterizing our novel nicotine vapor self administration mouse model alongside great scientists! @LoisAkinola @DamajLab sciencedirect.com/science/ar…
1
3
7
1,003
Harvard scientists are leaving academia for the private sector to fast-track biomedical breakthroughs. Michael Mina (eMed), Douglas Melton (Vertex), Stuart Schreiber (Arena Bioworks) cite funding delays & admin hurdles as key reasons. #BiomedicalResearch harvardmagazine.com/2025/01/…
12
85
3
480
59,594
Awesome job by Yumna, a very talented medical student. She will be a wonderful physician scientist! Thanks also to Belle @BuzziBelle, a wonderful graduate student in the lab!
Excited to share that my latest, first-author publication is now online! A huge thanks to Dr. Damaj for his mentorship and to all the contributors that helped it come together! @DamajLab doi.org/10.1177/026988112412…
7
357
Congratulations Julian! Nice work with several people in the Lab @BuzziBelle on spontaneous oxycodone withdrawal.
Happy to post my first paper in the Damaj lab @DamajLab 🍾🎊🎊 sciencedirect.com/science/ar…
3
12
835
Thank you @EMRumney for the interview and thank you @sejordt for alerting us on this emerging health issue.
Nicotine-like chemicals being used in vapes in the U.S. and beyond, such as 6-methyl nicotine, may be more potent and addictive than traditional nicotine. But they can also skirt regulations designed to control nicotine products. Here's my story: reuters.com/business/healthc…
4
195